1
|
Moussa M, Cauvin E, Le Piouffle A, Lucas O, Bidault A, Paillard C, Benoit F, Thuillier B, Treilles M, Travers MA, Garcia C. A MALDI-TOF MS database for fast identification of Vibrio spp. potentially pathogenic to marine mollusks. Appl Microbiol Biotechnol 2021; 105:2527-2539. [PMID: 33590268 PMCID: PMC7954726 DOI: 10.1007/s00253-021-11141-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2020] [Revised: 01/15/2021] [Accepted: 01/25/2021] [Indexed: 02/05/2023]
Abstract
In mollusk aquaculture, a large number of Vibrio species are considered major pathogens. Conventional methods based on DNA amplification and sequencing used to accurately identify Vibrio species are unsuitable for monitoring programs because they are time-consuming and expensive. The aim of this study was, therefore, to develop the MALDI-TOF MS method in order to establish a rapid identification technique for a large panel of Vibrio species. We created the EnviBase containing 120 main spectra projections (MSP) of the Vibrio species that are potentially responsible for mollusk diseases, comprising 25 species: V. aestuarianus, V. cortegadensis, V. tapetis and species belonging to the Coralliilyticus, Harveyi, Mediterranei, and Orientalis clades. Each MSP was constructed by the merger of raw spectra obtained from three different media and generated by three collaborating laboratories to increase the diversity of the conditions and thus obtain a good technique robustness. Perfect discrimination was obtained with all of the MSP created for the Vibrio species and even for very closely related species as V. europaeus and V. bivalvicida. The new EnviBase library was validated through a blind test on 100 Vibrio strains performed by our three collaborators who used the direct transfer and protein extraction methods. The majority of the Vibrio strains were successfully identified with the newly created EnviBase by the three laboratories for both protocol methods. This study documents the first development of a freely accessible database exclusively devoted to Vibrio found in marine environments, taking into account the high diversity of this genus. KEY POINTS: • Development of a MALDI-TOF MS database to quickly affiliate Vibrio species. • Increase of the reactivity when faced with Vibrio associated with mollusk diseases. • Validation of MALDI-TOF MS as routine diagnostic tool.
Collapse
Affiliation(s)
- M Moussa
- Ifremer, SG2M-LGPMM, Laboratoire de Génétique et Pathologie des Mollusques Marins, F-17390, La Tremblade, France
| | - E Cauvin
- Labeo-Manche, 1352 avenue de Paris, 50000, Saint-Lô, France
| | - A Le Piouffle
- Labocea, Avenue de la Plage des Gueux, 29330, Quimper, France
| | - O Lucas
- Qualyse, ZI Montplaisir, 79220, Champdeniers Saint-Denis, France
| | - A Bidault
- Univ Brest, CNRS, IRD, Ifremer, UMR6539 LEMAR, F-29280, Plouzané, France
| | - C Paillard
- Univ Brest, CNRS, IRD, Ifremer, UMR6539 LEMAR, F-29280, Plouzané, France
| | - F Benoit
- Labeo-Manche, 1352 avenue de Paris, 50000, Saint-Lô, France
| | - B Thuillier
- Labocea, Avenue de la Plage des Gueux, 29330, Quimper, France
| | - M Treilles
- Qualyse, ZI Montplaisir, 79220, Champdeniers Saint-Denis, France
| | - M A Travers
- Ifremer, SG2M-LGPMM, Laboratoire de Génétique et Pathologie des Mollusques Marins, F-17390, La Tremblade, France
- IHPE, Univ. Montpellier, CNRS, Ifremer, Univ. Perpignan Via Domitia, F-34090, Montpellier, France
| | - Céline Garcia
- Ifremer, SG2M-LGPMM, Laboratoire de Génétique et Pathologie des Mollusques Marins, F-17390, La Tremblade, France.
| |
Collapse
|
2
|
Desriac F, Le Chevalier P, Brillet B, Leguerinel I, Thuillier B, Paillard C, Fleury Y. Exploring the hologenome concept in marine bivalvia: haemolymph microbiota as a pertinent source of probiotics for aquaculture. FEMS Microbiol Lett 2014; 350:107-16. [PMID: 24286558 DOI: 10.1111/1574-6968.12308] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2013] [Revised: 10/02/2013] [Accepted: 10/17/2013] [Indexed: 02/05/2023] Open
Abstract
Haemolymph-associated microbiota of marine bivalves was explored for antibacterial activity against important aquaculture pathogens. A collection of 843 strains were cultured from the haemolymph of four bivalve species (Crassostrea gigas, Mytilus edulis, Pecten maximus and Tapes rhomboides) collected by deep-sea diving in the Glenan Archipelago (France). Cell-free culture supernatants were investigated for antibacterial activity using the well-diffusion assay. About 3% of haemolymph-associated cultivable bacteria displayed antibacterial activity toward Gram-negative pathogens. Among the active bacteria, Pseudoalteromonas strains exhibited the highest antibacterial activity. The cell-free culture supernatant of one of them, named hCg-51, was able to inhibit the growth of bacterial pathogens even after drastic dilution (1 : 1024). Hemocyte survival was not significantly altered in the presence of the haemolymph-associated strains assayed. Moreover, a dose-dependent beneficial effect on hemocyte survival rates was observed with the hCg-51 strain. These results suggest that haemolymph microbiota may participate in bivalve protection and therefore confer a health benefit on the host. As a result, the results highlight bivalve haemolymph microbiota as a promising novel source for aquaculture probiotics. This work also gives a first insight into the contribution of the haemolymph-associated microbiota as part of the bivalve 'hologenome'.
Collapse
Affiliation(s)
- Florie Desriac
- Université de Brest, EA3882, Laboratoire Universitaire de Biodiversité et Ecologie Microbienne (LUBEM), IFR148 ScInBioS, Institut Universitaire de Technologie, Quimper, France
| | | | | | | | | | | | | |
Collapse
|
3
|
Khayat RV, Routier E, Lanoy E, Thomas M, Cazenave H, Roy S, Thuillier B, Mateus C, Robert C. Profils des réponses et des rechutes des patients traités par vemurafenib pour un mélanome métastatique. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
4
|
Mateus C, Boussemart L, Thomas M, Routier E, Maksimovic L, Thuillier B, Hamoum I, Waille K, Kamsukom N, Lacroix L, Robert C. Profil évolutif des réponses et progressions tumorales chez 15 patients traités par inhibiteurs de BRAF. Ann Dermatol Venereol 2011. [DOI: 10.1016/j.annder.2011.09.158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
5
|
Giacchero D, Mateus C, Frigui F, Arnault JP, Maksimovic L, Thuillier B, Celebic A, Auperin A, Escudier B, Robert C. Management of adverse skin reactions to anticancer agents: The Gustave Roussy Institute experience. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e20638] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e20638 Background: Anticancer therapies are associated with various and multiple cutaneous side effects frequently impacting patients’ quality of life and sometimes impairing treatment continuation. Some new skin syndromes and their potential relationship with drug efficacy have been the subject of hundreds of publications over the last few years. Methods: All physicians in our institution were informed by mail about the creation of a weekly consultation and the availability of an emergency call number specifically devoted to the management of adverse cutaneous reactions to anticancer agents. Patients could be referred to us from our institute or from other french institutes. All cutaneous side effects were recorded. Type, severity, and duration of symptoms were described. Imputability of the drugs was evaluated according to semiological, chronological and bibliographical criteria. Results: Over a 4 months period, 215 visits have been performed for a total of 128 patients. 169 events were reported among which 123 were considered to be imputable to the drugs. Several new cutaneous side effects were identified. Hiring a beautician and a pedicure for aesthetic complaints or hand foot skin reactions has been necessary in several cases. Causative agents were mostly targeted therapies (76.4%). Topical (n=132) or systemic treatments (n=45) were prescribed. Temporary dose reduction or treatment interruption was recommended in 18 cases (10.6%). This pilot experience was highly appreciated by both patients and physicians. It was consolidated as a permanent organization at the frontier between oncology and dermatology with the creation of an adapted case report form (CRF). Conclusions: There is a real need for dermatological management of skin side effects in a cancer institute, especially if early trials testing new agents are performed. Dedicated collaboration between oncologists and dermatologists should be promoted as well as the creation of a global skin-oriented CRF in order to facilitate international collaborations and to evaluate the impact of this dermatological management on compliance to treatment. No significant financial relationships to disclose.
Collapse
Affiliation(s)
| | - C. Mateus
- Institut Gustave Roussy, Villejuif, France
| | - F. Frigui
- Institut Gustave Roussy, Villejuif, France
| | | | | | | | - A. Celebic
- Institut Gustave Roussy, Villejuif, France
| | - A. Auperin
- Institut Gustave Roussy, Villejuif, France
| | | | - C. Robert
- Institut Gustave Roussy, Villejuif, France
| |
Collapse
|
6
|
Guyon L, Tabarin T, Thuillier B, Antoine R, Broyer M, Boutou V, Wolf JP, Dugourd P. Femtosecond pump-probe experiments on trapped flavin: Optical control of dissociation. J Chem Phys 2008; 128:075103. [PMID: 18298175 DOI: 10.1063/1.2828558] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Laurent Guyon
- Université de Lyon, Université Lyon 1, CNRS, LASIM, Villeurbanne Cedex, France
| | | | | | | | | | | | | | | |
Collapse
|
7
|
Godard A, Fauchet F, Raher S, Jadoul M, Thuillier B, Dehart J, Soulillou JP, Baudrihaye M, Jacques Y, De Groote D. Generation of monoclonal antibodies against HILDA/LIF and their use in the quantitative assay of the cytokine. Cytokine 1993; 5:16-23. [PMID: 8485303 DOI: 10.1016/1043-4666(93)90019-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
An adoptive transfer immunization/fusion protocol in mice has been successfully used to raise a series of monoclonal antibodies directed against the Human Interleukin for DA-1a (HILDA)/Leukemia Inhibitory Factor (LIF) cytokine. These antibodies which were raised using recombinant HILDA/LIF purified from conditioned medium of transfected Chinese Hamster Ovary (CHO) cells also react with natural HILDA/LIF from the HSB2 T lymphoma cell line and unglycosylated HILDA/LIF produced in E. coli. They define four separate epitopes, one of which is involved in receptor binding and induction of biological activity. A sensitive sandwich immunoradiometric assay which is linear up to 5 ng/ml HILDA/LIF and can detect as low as 25 pg/ml of the cytokine has been developed.
Collapse
Affiliation(s)
- A Godard
- INSERM U.211 (Unité de Recherche sur les Effecteurs Lymphocytaires T), C.H.U. Nantes, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|